TNF and inflammatory bowel disease: Since some of the effects of TNF-α are mediated through LacCer synthesis, the latter could serve as a possible target for novel anti-inflammatory therapy in the future or as a marker of anti-TNF-α monoclonal antibody therapeutic effectiveness in IBD.